Skip to main content
Equibles

FEDERATED HERMES, INC.

Position in ZYME — Zymeworks Inc.

CIK 1056288 PITTSBURGH, PA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,914,188
+$346,643 QoQ
Shares Held
187,995
+3.1% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 202 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. ZYME ranks #71 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 719,905 $216,713,000
2 RYTM
Rhythm Pharmaceuticals, Inc.
 1,785,716 $198,268,046
3 REGN
Regeneron Pharmaceuticals, Inc.
 256,884 $160,177,448
4 MRNA
Moderna, Inc.
 1,794,778 $125,688,301
5 KYMR
Kymera Therapeutics, Inc.
 749,398 $85,933,468
6 EYPT
EyePoint, Inc.
 5,681,052 $81,239,042
7 ARGX
Argenx SE
 87,288 $80,983,187
8 ZBIO
Zenas BioPharma, Inc.
 3,116,805 $79,104,510

All Filings in ZYME

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,914,188 187,995
2026-03-31 $4,567,545 182,410
2025-12-31 $4,020,299 152,689
2025-09-30 $3,123,025 182,847
2025-06-30 $2,287,487 182,270
2025-03-31 $2,166,570 181,912
2024-12-31 $2,659,003 181,626
2024-09-30 $2,237,149 178,259
2024-06-30 $1,526,531 179,381
2024-03-31 $1,899,354 180,547
2023-12-31 $4,135 398